Discovery & Development

A start up company explains how their platform is helping to boost RNA therapeutics.

Why is self-amplifying mRNA gaining more and more attention in the vaccine space?

These fungi have some real nerve (developing properties).

How fungi help turn ocean trash into pharmaceutical platform molecules.

How do we further integrate real-world data into clinical research and approval processes?

The use of media panels for AAV process development shows improved media development efficiency and flexibility

Ulrike Gnad-Vogt talks us through CureVac’s efforts to target seasonal influenza

As the world continues to take on the post-COVID flu epidemic, we ask RQ Bio CEO Hugo Fry what part monoclonal antibodies play in new flu treatments

AI for drug discovery has enormous potential; to unlock it, we need to reset our mindset

Gene Sullivan, Chief Product Strategy Officer at Insmed, explores how new thinking could improve the research process for rare disease treatments